Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00203372
Status:
COMPLETED
Last Update Posted:
2015-10-12
First Post:
2005-09-12
Brief Title:
Neoadjuvant TAC Plus or Minus BevacizumabAVF3299
Sponsor:
Organization:
Translational Oncology Research International